Related references
Note: Only part of the references are listed.Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson's disease
Phillippa J. Carling et al.
PROGRESS IN NEUROBIOLOGY (2020)
Optogenetic Control of Spine-Head JNK Reveals a Role in Dendritic Spine Regression
Patrik Hollos et al.
ENEURO (2020)
Role of the endolysosomal system in Parkinson's disease
D. J. Vidyadhara et al.
JOURNAL OF NEUROCHEMISTRY (2019)
PaDuA: A Python Library for High-Throughput (Phospho)proteomics Data Analysis
Anna Ressa et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Autophagy and LRRK2 in the Aging Brain
Federica Albanese et al.
FRONTIERS IN NEUROSCIENCE (2019)
Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity
Asad Jan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Validation of the MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2018)
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers
Ye Zhao et al.
BRAIN (2018)
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Diana Chang et al.
NATURE GENETICS (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research
Rebekah G. Langston et al.
BIOCHEMICAL JOURNAL (2016)
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity
Danielle M. Gerhard et al.
DRUG DISCOVERY TODAY (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Presynaptic Protein Synthesis Is Required for Long-Term Plasticity of GABA Release
Thomas J. Younts et al.
NEURON (2016)
KIF5C S176 Phosphorylation Regulates Microtubule Binding and Transport Efficiency in Mammalian Neurons
Artur Padzik et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction
Jay Penney et al.
NATURE COMMUNICATIONS (2016)
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Martin Steger et al.
ELIFE (2016)
Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
E. Lobbestael et al.
SCIENTIFIC REPORTS (2016)
ABC50 mutants modify translation start codon selection
Joanna D. Stewart et al.
BIOCHEMICAL JOURNAL (2015)
Neuropathobiology of non-motor symptoms in Parkinson disease
Kurt A. Jellinger
JOURNAL OF NEURAL TRANSMISSION (2015)
Quantitative nature of overexpression experiments
Hisao Moriya
MOLECULAR BIOLOGY OF THE CELL (2015)
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease
Lorraine V. Kalia et al.
JAMA NEUROLOGY (2015)
The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases
Marina Mora et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibitions
Matthew J. Fell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson's Disease
Ian Martin et al.
CELL (2014)
Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease
Eugenie Mutez et al.
NEUROBIOLOGY OF DISEASE (2014)
Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation
Bernd K. Gilsbach et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research
Marco A. S. Baptista et al.
DISEASE MODELS & MECHANISMS (2013)
Axon degeneration in Parkinson's disease
Robert E. Burke et al.
EXPERIMENTAL NEUROLOGY (2013)
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
Laurie H. Sanders et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor
Alastair D. Reith et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria
Yi Zhao et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2012)
Rotenone, Paraquat, and Parkinson's Disease
Caroline M. Tanner et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease
Suzanne Lesage et al.
HUMAN MOLECULAR GENETICS (2011)
LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool
Giovanni Piccoli et al.
JOURNAL OF NEUROSCIENCE (2011)
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Xianming Deng et al.
NATURE CHEMICAL BIOLOGY (2011)
Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates
Timothy J. Collier et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
Stephan Gehrke et al.
NATURE (2010)
In situ visualization and dynamics of newly synthesized proteins in rat hippocampal neurons
Daniela C. Dieterich et al.
NATURE NEUROSCIENCE (2010)
Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease
Graham D. Pavitt et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
A highly reproducible rotenone model of Parkinson's disease
Jason R. Cannon et al.
NEUROBIOLOGY OF DISEASE (2009)
Clinical features of LRRK2 parkinsonism
Kristoffer Haugarvoll et al.
PARKINSONISM & RELATED DISORDERS (2009)
Re-programming of translation following cell stress allows IRES-mediated translation to predominate
Keith A. Spriggs et al.
BIOLOGY OF THE CELL (2008)
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Yuzuru Imai et al.
EMBO JOURNAL (2008)
Ancient origin of the Parkinson disease gene LRRK2
Ignacio Marin
JOURNAL OF MOLECULAR EVOLUTION (2008)
Survival assay of transiently transfected dopaminergic neurons
Li-ying Yu et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
The Wnt pool of glycogen synthase kinase 3β is critical for trophic-deprivation-induced neuronal death
Vesa Hongisto et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study
Mary M. Hulihan et al.
LANCET NEUROLOGY (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Activation of the unfolded protein response in Parkinson's disease
J. J. M. Hoozemans et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey et al.
NEUROLOGY (2007)
Identification of potential protein interactors of Lrrk2
Justus C. Daechsel et al.
PARKINSONISM & RELATED DISORDERS (2007)
Different modes and potencies of translational repression by sequence-specific RNA-protein interaction at the 5′-UTR
Minghua Nie et al.
NUCLEIC ACIDS RESEARCH (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
The N-terminal domain of the human eIF2β subunit and the CK2 phosphorylation sites are required for its function
F Llorens et al.
BIOCHEMICAL JOURNAL (2006)
Coping with stress: eIF2 kinases and translational control
RC Wek et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Selective vulnerability of dopaminergic neurons to microtubule depolymerization
Y Ren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture:: Role of microtubule-associated protein 2 as an effector
B Björkblom et al.
JOURNAL OF NEUROSCIENCE (2005)
L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats
M Alam et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter
MS van der Knaap et al.
ANNALS OF NEUROLOGY (2002)
The human ribosomal protein genes: Sequencing and comparative analysis of 73 genes
M Yoshihama et al.
GENOME RESEARCH (2002)
The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bε at Ser539 and the microtubule-associated protein tau at Thr212:: potential role for DYRK as a glycogen synthase kinase 3-priming kinase
YL Woods et al.
BIOCHEMICAL JOURNAL (2001)
Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts
PAJ Leegwater et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet et al.
NATURE NEUROSCIENCE (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
